Pfizer, Inc.

PFE

US7170811035

Pharmaceuticals

Market Closed - Nyse Other stock markets 01:30:02 10/07/2025 am IST			Pre-market 04:40:01 pm
25.56 ^USD	-0.23%		25.54	-0.08%

04:36pm	Pfizer, Astellas Say Xtandi Shows Favourable Overall Survival in Prostate Cancer Study	MT
04:23pm	Xtandi plus leuprolide significantly improves survival outcomes in men with non-metastatic hormone-sensitive prostate cancer with high-risk biochemical recurrence	RE

Citigroup Adjusts Price Target on Pfizer to $25 From $23, Maintains Neutral Rating

Published on 30/04/2025 at 16:46

This article is reserved for members

Unlock the article: REGISTER NOW!

100% Free Registration

Already a customer? Log In

Latest news about Pfizer, Inc.

Pfizer, Astellas Say Xtandi Shows Favourable Overall Survival in Prostate Cancer Study	04:36pm	MT
Xtandi plus leuprolide significantly improves survival outcomes in men with non-metastatic hormone-sensitive prostate cancer with high-risk biochemical recurrence	04:23pm	RE
EU's von der Leyen survives parliament confidence vote	04:04pm	RE
EU's von der Leyen survives parliament confidence vote	04:04pm	RE
Major deals involving U.S. drugmakers and biotechs over the past decade	09/07	RE
Transgene SA Announces Board Changes	09/07	CI
Health Rounds: Experimental Bayer drug eases menopause-like symptoms from breast cancer therapy	09/07	RE
Trump says pharmaceutical tariffs could reach 200%	09/07	RE
Sector Update: Health Care Stocks Advance Late Afternoon	09/07	MT
Sector Update: Health Care Stocks Advance in Afternoon Trading	08/07	MT
Pharma Stocks Pare Gains After Trump Reportedly Threatens 200% Tariff on Imported Drugs	08/07	MT
Pharma Stocks Pare Gains After Trump Reportedly Threatens 200% Tariff on Imported Drugs	08/07	MT
Pfizer's Chief Corporate Officer Sally Susman to Step Down	08/07	MT
FDA says to discontinue Hospira's morphine sulfate, injection, 10 mg/1 ml, 4 mg/1 ml, 8 mg/1 ml - website	08/07	RE
PFIZER INC : JP Morgan reiterates its Neutral rating	08/07	ZD
UK's MHRA flags Guillain-Barré syndrome risk post Abrysvo & Arexvy vaccination in adults 60 years & older	07/07	RE
HSBC Adjusts Price Target on Pfizer to $28 From $26, Maintains Buy Rating	07/07	MT
Activist investor Starboard discloses 9% stake in Tripadvisor, says shares undervalued	04/07	RE
Activist Starboard Value takes stake in online travel company Tripadvisor, stock jumps	03/07	RE
Activist Starboard Value takes stake in online travel company Tripadvisor, stock jumps	03/07	RE
US CDC accepts ousted vaccine panel's recommendations for RSV, meningococcal shots	03/07	RE
US CDC accepts ousted vaccine panel's recommendations for RSV, meningococcal shots	02/07	RE
US FDA approves Regeneron's blood cancer therapy	02/07	RE
Organon abandons endometriosis pain drug development after trial failure	02/07	RE
Health Rounds: 3D printed insulin-producing cells show promise for type 1 diabetes in lab tests	02/07	RE

Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (47.4%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (26.2%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (24.5%); - other (1.9%). The United States accounts for 60.8% of net sales.

Employees

81,000

Sector

Pharmaceuticals

Calendar

25/07 - Détachement de

More about the company